Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CardieX ( (AU:CDX) ) has provided an announcement.
Cardiex Limited has issued 42,500,000 fully paid ordinary shares to sophisticated and institutional investors at $0.04 per share, with an additional 18,409,580 shares pending shareholder approval. This move allows the company to enhance its financial position and potentially expand its market presence, as the shares can be traded immediately under the exemption provided by section 708A(5) of the Corporations Act.
More about CardieX
Cardiex is a company focused on advancing medical technology for vascular health. Their products include medical and home health devices, as well as digital solutions for hypertension, cardiovascular disease, and other vascular health disorders, leveraging their SphygmoCor® vascular biomarker technology. Cardiex is listed on the Australian Stock Exchange under the ticker ASX:CDX.
Average Trading Volume: 247,420
Technical Sentiment Signal: Sell
Current Market Cap: A$17.87M
Learn more about CDX stock on TipRanks’ Stock Analysis page.